138 related articles for article (PubMed ID: 12682480)
1. Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia.
Derhaschnig U; Pernerstorfer T; Knechtelsdorfer M; Hollenstein U; Panzer S; Jilma B
Crit Care Med; 2003 Apr; 31(4):1108-12. PubMed ID: 12682480
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers.
van Eijk LT; Dorresteijn MJ; Smits P; van der Hoeven JG; Netea MG; Pickkers P
Crit Care Med; 2007 Jun; 35(6):1464-9. PubMed ID: 17452928
[TBL] [Abstract][Full Text] [Related]
4. Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin.
Jilma B; Blann A; Pernerstorfer T; Stohlawetz P; Eichler HG; Vondrovec B; Amiral J; Richter V; Wagner OF
Am J Respir Crit Care Med; 1999 Mar; 159(3):857-63. PubMed ID: 10051263
[TBL] [Abstract][Full Text] [Related]
5. Prevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparin.
Maugeri N; de Gaetano G; Barbanti M; Donati MB; Cerletti C
Haematologica; 2005 Jun; 90(6):833-9. PubMed ID: 15951297
[TBL] [Abstract][Full Text] [Related]
6. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
Harada N; Okajima K; Uchiba M
Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
[TBL] [Abstract][Full Text] [Related]
7. Effects of anticoagulation on thrombopoietin release during endotoxemia.
Jilma-Stohlawetz P; Folman CC; von dem Borne AE; Pernerstorfer T; Hollenstein U; Knechtelsdorfer M; Eichler HG; Jilma B
J Lab Clin Med; 2001 Jan; 137(1):64-9. PubMed ID: 11150025
[TBL] [Abstract][Full Text] [Related]
8. Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia.
Lynn M; Rossignol DP; Wheeler JL; Kao RJ; Perdomo CA; Noveck R; Vargas R; D'Angelo T; Gotzkowsky S; McMahon FG
J Infect Dis; 2003 Feb; 187(4):631-9. PubMed ID: 12599080
[TBL] [Abstract][Full Text] [Related]
9. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis.
Paterson RL; Galley HF; Webster NR
Crit Care Med; 2003 Nov; 31(11):2574-8. PubMed ID: 14605526
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes.
Hochart H; Jenkins PV; Smith OP; White B
Br J Haematol; 2006 Apr; 133(1):62-7. PubMed ID: 16512830
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
Renckens R; Weijer S; de Vos AF; Pater JM; Meijers JC; Hack CE; Levi M; van der Poll T
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):483-8. PubMed ID: 14739127
[TBL] [Abstract][Full Text] [Related]
12. Differential dose-dependent effects of prednisolone on shedding of endothelial adhesion molecules during human endotoxemia.
Lemaire LC; de Kruif MD; Giebelen IA; van Zoelen MA; van't Veer C; van der Poll T
Immunol Lett; 2008 Dec; 121(2):93-6. PubMed ID: 18930765
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG
Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642
[TBL] [Abstract][Full Text] [Related]
14. Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.
Derhaschnig U; Schweeger-Exeli I; Marsik C; Cardona F; Minuz P; Jilma B
Platelets; 2010; 21(5):320-8. PubMed ID: 20608787
[TBL] [Abstract][Full Text] [Related]
15. Dobutamine does not influence inflammatory pathways during human endotoxemia.
Lemaire LC; de Kruif MD; Giebelen IA; Levi M; van der Poll T; Heesen M
Crit Care Med; 2006 May; 34(5):1365-71. PubMed ID: 16540959
[TBL] [Abstract][Full Text] [Related]
16. Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
Maddineni J; Jeske WP; Baltasar F; Cornelli U; Manoni M; Hoppensteadt DA; Fareed J
Clin Appl Thromb Hemost; 2006 Jul; 12(3):311-7. PubMed ID: 16959684
[TBL] [Abstract][Full Text] [Related]
17. Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial.
Pernerstorfer T; Schmid R; Bieglmayer C; Eichler HG; Kapiotis S; Jilma B
Clin Pharmacol Ther; 1999 Jul; 66(1):51-7. PubMed ID: 10430109
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.
Shannon E; Noveck R; Sandoval F; Kamath B; Kearney M
Transl Res; 2007 Nov; 150(5):275-80. PubMed ID: 17964516
[TBL] [Abstract][Full Text] [Related]
19. Enalapril does not alter adhesion molecule levels in human endotoxemia.
Graninger M; Marsik C; Dukic T; Wagner OF; Blann AD; Jilma B
Shock; 2003 May; 19(5):448-51. PubMed ID: 12744488
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia.
de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van der Poll T
J Infect Dis; 2001 Jun; 183(12):1815-8. PubMed ID: 11372037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
